We caught up with Professor Peter Clemmensen (University Heart Center Hamburg, Hamburg, Germany) to discuss the recent ESC Guidelines update for non-ST elevation myocardial infarction (N-STEMI) and how these may affect outcomes and clinical practice.
- What are the major unmet needs in the management of acute myocardial infarction in patients presenting without ST-segment elevation? (0.22)
- How do non-ST elevation myocardial infarction (N-STEMI) outcomes vary across Europe? (1.31)
- Could you give us an overview of what’s new in the guidelines? (2.35)
- What will be the major impact of these guidelines on clinical practice? (5.40)
- What practical advice would you like to share with physicians managing N-STEMI in their patients? (7.00)
Speaker disclosures: Professor Peter Clemmensen has previously or currently been involved in research contracts, consulting, speakers bureau or received research and educational grants from Abbott, AstraZeneca, Aventis, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Eli-Lilly, Evolva, Fibrex, Janssen, Merck, Myogen, Medtronic, Mitsubishi Pharma, The Medicines Company, Nycomed, Organon, Pfizer, Pharmacia, Regado, Sanofi, Searle, Servier and ViFor Pharma.
Support: Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Professor Peter Clemmensen, September 2020.
Share this Video
Related Videos In Cardiovascular Disease
William Schulyer-Jones, ACC 2021 – Findings from the ADAPTIVE study
We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease. Abstract title: Aspirin Dosing: A […]
Gustavo Samaja, ESC 2020 – Myocardial Infarction with no Obstructive Coronary Arteries
We spoke to Dr Gustavo Samaja (Policlinico Bancario, Buenos Aires, Argentina) about myocardial infarction with no obstructive coronary arteries (MINOCA), and especially its prevalence and importance during the COVID-19 pandemic. Questions Could you give us a brief overview of myocardial infarction with no obstructive coronary arteries (MINOCA)? (0:33) How prevalent is MINOCA and what […]
David Playford, ESC 2020 – Diastolic Function and Mortality Part 1
We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality. Questions What are the prognostic implications of diastolic dysfunction? (0:07) How do you classify patients by diastolic function? (1:18) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!